Arvinas Inc (ARVN)

Arvinas Inc (ARVN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $472M; returns 1 day -5.4%, 1 week +4.7%, 1 year -20.3%.

Arvinas Inc. (ARVN) is a clinical-stage biotechnology company pioneering the discovery, development, and commercialization of therapies based on Targeted Protein Degradation (TPD) using its proprietary PROteolysis TArgeting Chimera (PROTAC®) platform.

Groups ARVN belongs to

• Biotechnology
• Buying Back Stock
• Clinical Stage Biotech
• Biopharmaceutical
• Healthcare
• Life Sciences
• Oncology
• Cancer Therapeutics
• Drug Discovery
• Breast Cancer Treatment
• R&D
• Precision Medicine
• Neuroscience

ARVN financial model: income statement, cash flow and balance sheet